Search details
1.
Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall.
Bioconjug Chem
; 31(2): 360-368, 2020 02 19.
Article
in English
| MEDLINE | ID: mdl-31095372
2.
Prospective Study of Systemic Yttrium-90 Elution during Radioembolization of Hepatic Metastases.
J Vasc Interv Radiol
; 31(12): 2007-2013.e1, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33143997
3.
Automation of pattern recognition analysis of dynamic contrast-enhanced MRI data to characterize intratumoral vascular heterogeneity.
Magn Reson Med
; 79(3): 1736-1744, 2018 03.
Article
in English
| MEDLINE | ID: mdl-28727185
4.
Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer.
Eur J Nucl Med Mol Imaging
; 44(10): 1682-1691, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28540417
5.
[89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Eur J Nucl Med Mol Imaging
; 49(2): 783-785, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34498111
6.
Correction to: [89Zr]ZrhuJ591 immunoPET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Eur J Nucl Med Mol Imaging
; 49(6): 2102, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35266033
7.
Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer.
Proc Natl Acad Sci U S A
; 111(20): 7254-9, 2014 May 20.
Article
in English
| MEDLINE | ID: mdl-24785505
8.
PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization Study.
Bioconjug Chem
; 27(9): 2014-23, 2016 09 21.
Article
in English
| MEDLINE | ID: mdl-27396694
9.
Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.
Bioconjug Chem
; 25(12): 2123-8, 2014 Dec 17.
Article
in English
| MEDLINE | ID: mdl-25418333
10.
Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives.
Mol Pharm
; 11(11): 3965-73, 2014 Nov 03.
Article
in English
| MEDLINE | ID: mdl-24779727
11.
Targeting breast tumors with pH (low) insertion peptides.
Mol Pharm
; 11(8): 2896-905, 2014 Aug 04.
Article
in English
| MEDLINE | ID: mdl-25004202
12.
(89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer.
Pharm Res
; 30(3): 878-88, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23224977
13.
Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation.
Bioconjug Chem
; 23(8): 1557-66, 2012 Aug 15.
Article
in English
| MEDLINE | ID: mdl-22784215
14.
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma.
Commun Biol
; 5(1): 1260, 2022 11 17.
Article
in English
| MEDLINE | ID: mdl-36396952
15.
In vivo visualization of PARP inhibitor pharmacodynamics.
JCI Insight
; 6(8)2021 04 22.
Article
in English
| MEDLINE | ID: mdl-33884961
16.
Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status.
J Nucl Med
; 61(5): 665-670, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31836680
17.
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models.
Mol Cancer Ther
; 18(7): 1195-1204, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31072830
18.
Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model.
Mol Imaging Biol
; 20(5): 808-815, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29508263
19.
Imaging EGFR and HER3 through 89Zr-labeled MEHD7945A (Duligotuzumab).
Sci Rep
; 8(1): 9043, 2018 06 13.
Article
in English
| MEDLINE | ID: mdl-29899472
20.
18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.
J Nucl Med
; 58(10): 1567-1573, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28360207